BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 16571898)

  • 1. Adduct-specific monoclonal antibodies for the measurement of cisplatin-induced DNA lesions in individual cell nuclei.
    Liedert B; Pluim D; Schellens J; Thomale J
    Nucleic Acids Res; 2006 Mar; 34(6):e47. PubMed ID: 16571898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of cisplatin 1,2-intrastrand guanine-guanine DNA adducts in human leukocytes by high-performance liquid chromatography coupled to inductively coupled plasma mass spectrometry.
    Harrington CF; Le Pla RC; Jones GD; Thomas AL; Farmer PB
    Chem Res Toxicol; 2010 Aug; 23(8):1313-21. PubMed ID: 20666396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of a high-affinity monoclonal antibody specific for 7-(benzo[alpha]pyren-6-yl) guanine and its application in a competitive enzyme-linked immunosorbent assay.
    Casale GP; Rogan EG; Stack D; Devanesan P; Cavalieri EL
    Chem Res Toxicol; 1996 Sep; 9(6):1037-43. PubMed ID: 8870993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific adducts recognised by a monoclonal antibody against cisplatin-modified DNA.
    Meczes EL; Azim-Araghi A; Ottley CJ; Pearson DG; Tilby MJ
    Biochem Pharmacol; 2005 Dec; 70(12):1717-25. PubMed ID: 16259963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In situ detection of acetylaminofluorene-DNA adducts in human cells using monoclonal antibodies.
    Iwamoto TA; Kobayashi N; Imoto K; Yamamoto A; Nakamura Y; Yamauchi Y; Okumura H; Tanaka A; Hanaoka F; Shibutani S; Miyagawa S; Mori T
    DNA Repair (Amst); 2004 Nov; 3(11):1475-82. PubMed ID: 15380103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The formation and persistence of carboplatin-DNA adducts in rats.
    Blommaert FA; Michael C; van Dijk-Knijnenburg HC; Schornagel JH; den Engelse L; Fichtinger-Schepman AM
    Cancer Chemother Pharmacol; 1996; 38(3):273-80. PubMed ID: 8646803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive detection of DNA modifications induced by cisplatin and carboplatin in vitro and in vivo using a monoclonal antibody.
    Tilby MJ; Johnson C; Knox RJ; Cordell J; Roberts JJ; Dean CJ
    Cancer Res; 1991 Jan; 51(1):123-9. PubMed ID: 1703029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells.
    Chijiwa S; Masutani C; Hanaoka F; Iwai S; Kuraoka I
    Carcinogenesis; 2010 Mar; 31(3):388-93. PubMed ID: 20015866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High accumulation of platinum-DNA adducts in strial marginal cells of the cochlea is an early event in cisplatin but not carboplatin ototoxicity.
    Thomas JP; Lautermann J; Liedert B; Seiler F; Thomale J
    Mol Pharmacol; 2006 Jul; 70(1):23-9. PubMed ID: 16569706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I and pharmacokinetic study of SPI-77, a liposomal encapsulated dosage form of cisplatin.
    Meerum Terwogt JM; Groenewegen G; Pluim D; Maliepaard M; Tibben MM; Huisman A; ten Bokkel Huinink WW; Schot M; Welbank H; Voest EE; Beijnen JH; Schellens JM
    Cancer Chemother Pharmacol; 2002 Mar; 49(3):201-10. PubMed ID: 11935212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of the formation and removal of cisplatin-DNA adducts in blood cells and tumor tissue of cancer patients receiving chemotherapy: comparison with in vitro adduct formation.
    Fichtinger-Schepman AM; van der Velde-Visser SD; van Dijk-Knijnenburg HC; van Oosterom AT; Baan RA; Berends F
    Cancer Res; 1990 Dec; 50(24):7887-94. PubMed ID: 2253228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistence of platinum-ammine-DNA adducts in gonads and kidneys of rats and multiple tissues from cancer patients.
    Poirier MC; Reed E; Litterst CL; Katz D; Gupta-Burt S
    Cancer Res; 1992 Jan; 52(1):149-53. PubMed ID: 1727376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA binding by antitumor trans-[PtCl2(NH3)(thiazole)]. Protein recognition and nucleotide excision repair of monofunctional adducts.
    Kasparkova J; Novakova O; Farrell N; Brabec V
    Biochemistry; 2003 Jan; 42(3):792-800. PubMed ID: 12534292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of a monoclonal antibody to detect DNA damage caused by the anticancer drug cis-diamminedichloroplatinum (II) in vivo and in vitro.
    Chao CC; Shieh TC; Huang H
    FEBS Lett; 1994 Oct; 354(1):103-9. PubMed ID: 7957889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequencies of mutagenic translesion DNA synthesis over cisplatin-guanine intra-strand crosslinks in lacZ plasmids propagated in human cells.
    Fujikawa Y; Kawanishi M; Kuraoka I; Yagi T
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Aug; 770():23-8. PubMed ID: 25344160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of human breast cancer xenografts on therapy with humanized monoclonal antibody to HER-2 receptor and DNA-reactive drugs.
    Pietras RJ; Pegram MD; Finn RS; Maneval DA; Slamon DJ
    Oncogene; 1998 Oct; 17(17):2235-49. PubMed ID: 9811454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF; Koberle B; Masters JR; Kelland LR
    Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A monofunctional derivative of melphalan: preparation, DNA alkylation products, and determination of the specificity of monoclonal antibodies that recognize melphalan-DNA adducts.
    Tilby MJ; McCartney H; Gould KA; O'Hare CC; Hartley JA; Hall AG; Golding BT; Lawley PD
    Chem Res Toxicol; 1998 Oct; 11(10):1162-8. PubMed ID: 9778312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inductively coupled plasma mass spectroscopy quantitation of platinum-DNA adducts in peripheral blood leukocytes of patients receiving cisplatin- or carboplatin-based chemotherapy.
    Bonetti A; Apostoli P; Zaninelli M; Pavanel F; Colombatti M; Cetto GL; Franceschi T; Sperotto L; Leone R
    Clin Cancer Res; 1996 Nov; 2(11):1829-35. PubMed ID: 9816137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in cervix carcinoma HeLa cells: relation to DNA repair.
    Chao CC
    Mol Pharmacol; 1994 Jun; 45(6):1137-44. PubMed ID: 8022407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.